News

Clinical Trials Arena2h
AstraZeneca’s Phase III trial of baxdrostat shows mean SBP reduction
AstraZeneca has reported positive outcomes from the BaxHTN Phase III trial of the highly selective ASI, baxdrostat.
Clinical Trials Arena2h
MSD progresses once-monthly HIV PrEP into Phase III
MSD unveiled the launch of the Phase III trials of MK-8527 at the International AIDS Society (IAS) 2025 conference.
Clinical Trials Arena21h
Amylyx presents new exploratory analyses from avexitide trials for PBH
Amylyx has presented new exploratory analyses from the Phase II PREVENT and Phase IIb trials of avexitide for PBH treatment.